Clinical trials Archives

National Cancer Institute selects Kaiser Permanente for new Cancer Screening Research Network

February 21, 2024

The National Cancer Institute, part of the National Institutes of Health, selected Kaiser Permanente Northern California as one of the institutions to launch a new national clinical trials network to evaluate emerging technologies for cancer screening.

Kaiser Permanente research included in national clinical oncology conference

July 7, 2023

Investigators from the Division of Research and physicians from The Permanente Medical Group presented research on topics ranging from care delivery to cancer survivorship at the 2023 American Society of Clinical Oncology conference.

Clinical trials expand options for patients with heart problems

May 18, 2023

Kaiser Permanente study teams enroll members in large, national cardiology clinical trials setting new standards for care.

Home-delivered, medically tailored meals may benefit recently hospitalized patients with heart failure

August 25, 2022

A new Kaiser Permanente study finds promise in ‘food as medicine’ delivery for some — but not all — patients with chronic conditions.

Lifestyle coaching helps Black adults control high blood pressure

May 18, 2022

A new Kaiser Permanente study found that a culturally tailored program could lead to long-term benefits in adults with hypertension.

Kaiser Permanente researchers and physicians take part in leading clinical oncology conference

June 22, 2021

Research presented at the American Society for Clinical Oncology annual meeting amplified the ways the Division of Research and The Permanente Medical Group advance cancer care.

COVID-19 vaccine trial enrolls children aged 5-11 at 3 sites in Northern California

June 9, 2021

About 75 children are scheduled to receive their first vaccination against COVID-19 as part of the Pfizer/BioNTech vaccine clinical trial through Kaiser Permanente Northern California.

Blood clot risk low in non-hospitalized COVID-19 patients

April 5, 2021

COVID-19 patients who are not hospitalized are at low risk of developing blood clots and should not routinely be prescribed blood thinners, a new Kaiser Permanente research letter suggests.

Kaiser Permanente Northern California deepens its COVID-19 research agenda

October 13, 2020

Researchers and clinicians with Kaiser Permanente Northern California are developing a wide-ranging research agenda to beat COVID-19, working at the accelerated pace demanded by a worldwide pandemic.

Telehealth appointments improve follow-up care in patients with heart failure

September 24, 2020

Kaiser Permanente study is the first to compare early telehealth approach to early in-person follow-up to prevent hospital readmissions.

New virtual, innovative clinical trial for adults at high risk for respiratory illnesses

August 7, 2020

Kaiser Permanente researchers will see if a drug used to reduce risk of heart attack and stroke can also prevent or reduce complications from viral respiratory illnesses in older adults with heart disease.

COVID-19 clinical studies ramp up quickly at Kaiser Permanente Northern California

April 28, 2020

In the race to find safe and effective treatments for seriously ill patients with COVID-19, Kaiser Permanente Northern California (KPNC) is enrolling patients in nationwide clinical trials and pursuing other innovative treatment options.

Population-level estimates show wide age range of adults hospitalized with COVID-19

April 24, 2020

A JAMA study, using data on patients hospitalized in March from all 21 Kaiser Permanente Northern California hospitals, is one of the first U.S. studies to look at overall hospitalization admissions of COVID-19 patients.

KP Research Radio: A promising treatment for ovarian cancer

October 7, 2019

5 Questions for…Dr. Michael A. Bookman, co-leader of a clinical trial that could provide an important new treatment option for women with advanced gynecological cancers.

World’s Most Impactful Researchers List Includes Kaiser Permanente Northern California Scientist and Oncologist

November 30, 2017

Alan Go, MD, of the Kaiser Permanente Division of Research, and Kaiser Permanente Northern California oncologist Louis Fehrenbacher, MD, are among the less than 400 people named as Highly Cited Researchers in clinical medicine for 2017 by Clarivate Analytics. The annual list recognizes investigators whose research ranks in the top 1 percent most cited works in their field, indicating exceptional scientific impact.

Research Spotlight

Categories

Clinical trials